Intrinsic Value of S&P & Nasdaq Contact Us

Ingevity Corporation NGVT NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
$282.54
+280.7%
Analyst Price Target
$76.67
+3.3%

Ingevity Corporation (NGVT) reported total assets of $1.65B and total liabilities of $1.62B for quarter ending 2025-12-31, resulting in total equity of $29.7M.

The company held $78.1M in cash and short-term investments. Total debt stood at $1.24B, with net debt of $1.16B. The Debt-to-Equity (D/E) ratio was 41.84 (leveraged).

Current ratio is 1.15, suggesting adequate short-term liquidity. Interest coverage is 2.3x (weak).

Criteria supported by this page:

  • HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (60/100) — Total assets $1.65B and equity $29.7M support the company's competitive scale
  • VALUE (72/100) — Debt-to-Equity 41.84 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
72/100
Price-to-Earnings & upside
→ Valuation
FUTURE
67/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
60/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Ingevity Corporation Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $1.65B$1.83B$1.88B$2.06B
Total Liabilities $1.62B$1.7B$1.76B$1.82B
Total Debt $1.24B$1.29B$1.38B$1.44B
Cash & Investments $78.1M$83.4M$76.9M$71.5M
Total Stockholders Equity $29.7M$138.1M$120.7M$234.6M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message